Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Manchester United A | MANU | Jan 17, 2025 | 16.01 | -1.42 |
Mangoceuticals | MGRX | Jan 17, 2025 | 2.61 | -2.61 |
Manhattan Associates | MANH | Jan 17, 2025 | 273.43 | -0.73 |
Manhattan Bridge Capital | LOAN | Jan 17, 2025 | 5.67 | +0.71 |
Manitex International | MNTX | Jan 17, 2025 | 5.80 | 0.00 |
Manitowoc | MTW | Jan 17, 2025 | 9.28 | +1.53 |
Mannatech | MTEX | Jan 17, 2025 | 11.00 | -1.79 |
MannKind | MNKD | Jan 17, 2025 | 6.01 | 0.00 |
ManpowerGroup | MAN | Jan 17, 2025 | 59.54 | +0.34 |
Manulife Financial | MFC | Jan 17, 2025 | 30.61 | -0.71 |
Maplebear | CART | Jan 17, 2025 | 46.32 | -0.56 |
Marathon Digital | MARA | Jan 17, 2025 | 19.91 | +8.80 |
Marathon Petroleum | MPC | Jan 17, 2025 | 152.70 | +0.66 |
Maravai LifeSciences A | MRVI | Jan 17, 2025 | 4.77 | +4.38 |
Marblegate Acquisition A | GATE | Jan 17, 2025 | 10.86 | 0.00 |
Marchex B | MCHX | Jan 17, 2025 | 1.92 | -1.03 |
Marcus | MCS | Jan 17, 2025 | 19.82 | +0.30 |
Marcus & Millichap | MMI | Jan 17, 2025 | 36.63 | +1.30 |
Marex Group | MRX | Jan 17, 2025 | 33.75 | +1.35 |
Marin Software | MRIN | Jan 17, 2025 | 2.12 | +0.95 |
Marine Petroleum Trust U | MARPS | Jan 17, 2025 | 4.37 | -1.59 |
Marine Products | MPX | Jan 17, 2025 | 9.14 | -0.11 |
MarineMax | HZO | Jan 17, 2025 | 28.01 | +1.52 |
Marinus Pharmaceuticals | MRNS | Jan 17, 2025 | 0.54 | -0.22 |
Maris-Tech | MTEK | Jan 17, 2025 | 3.73 | -2.86 |
Markel | MKL | Jan 17, 2025 | 1 774.07 | +0.28 |
Marker Therapeutics | MRKR | Jan 17, 2025 | 2.46 | -7.52 |
Market Vectors Bdc Income ETF | BIZD | Jan 17, 2025 | 17.06 | +0.18 |
Market Vectors Investment Grade | FLTR | Jan 17, 2025 | 25.51 | +0.16 |
Market Vectors Israel ETF | ISRA | Jan 17, 2025 | 45.45 | +0.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.